Home > Financial Ratios > SEQUENT SCIENTIFIC

SEQUENT SCIENTIFIC
Core EBITDA Growth

    Back to All Ratios
SEQUENT SCIENTIFIC is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SEQUENT SCIENTIFIC
Please provide your vote to see the results

SEQUENT SCIENTIFIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 294.50-84.74-45.4522.1835.03

What is the latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC ?

The latest Core EBITDA Growth ratio of SEQUENT SCIENTIFIC is 294.50 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024294.50
Mar2023-84.74
Mar2022-45.45
Mar202122.18
Mar202035.03

How is Core EBITDA Growth of SEQUENT SCIENTIFIC Trending?

Years Core EBITDA Growth % Change
Mar2024 294.5
Positive
Mar2023 -84.74
Negative
Mar2022 -45.45
Negative
Mar2021 22.18
-36.68
Mar2020 35.03 -

Other Financial Ratios of SEQUENT SCIENTIFIC


Compare Core EBITDA Growth ratio of peers of SEQUENT SCIENTIFIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC ₹3,281.4 Cr -9.5% -13.4% 13.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,339.0 Cr 5.9% 0.7% 6.3% Stock Analytics
DIVIS LABORATORIES ₹150,507.0 Cr 2.9% -5% 57.1% Stock Analytics
CIPLA ₹120,581.0 Cr 2.1% 3% -0.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,569.0 Cr -0.3% -0.1% 14.3% Stock Analytics
DR REDDYS LABORATORIES ₹95,999.9 Cr 2.7% -5.4% -12.1% Stock Analytics


SEQUENT SCIENTIFIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SEQUENT SCIENTIFIC

-9.5%

-13.4%

13.4%

SENSEX

-0.2%

-2.8%

0.9%


You may also like the below Video Courses